Abstract
Hypophosphatasia (HPP) is due to deficient activity of the tissue-nonspecific isoenzyme of alkaline phosphatase (TNAP). This enzyme cleaves extracellular substrates inorganic pyrophosphates (PPi) , pyridoxal-5′-phosphate (PLP), phosphoethanolamine (PEA) and nucleotides , and probably other substrates not yet identified. During the last 15 years the role of TNAP in mineralization, and to a less degree in brain, has been investigated, providing hypotheses and explanations for both bone and neuronal HPP phenotypes. ALPL, the gene encoding TNAP, is subject to many mutations, mostly missense mutations . A few number of mutations are recurrently found and may be quite frequent in particular populations. This reflects founder effects. The great variety of mutations results in a great number of compound heterozygous genotypes and in highly variable clinical expressivity. A good correlation was observed between the severity of the disease and in vitro enzymatic activity of the mutant protein measured after site-directed mutagenesis. Many missense mutations found in severe hypophosphatasia produced a mutant protein that failed to reach the cell membrane , was accumulated in the cis-Golgi and was subsequently degraded in the proteasome. Missense mutations located in the catalytic site or in the homodimer interface were often shown by site-directed mutagenesis to have a dominant negative effect. Currently molecular diagnosis of HPP is based on the sequencing of the coding sequence of ALPL that allows detection of approximately 95 % of mutations in severe cases. In addition, other genes, especially genes encoding proteins involved in the regulation of extracellular PPi concentration, could modify the phenotype (modifier genes).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baumgartner-Sigl S, Haberlandt E, Mumm S, Scholl-Burgi S, Sergi C, Ryan L, Ericson KL, Whyte MP, Hogler W (2007) Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T > C, p. M226T; c.1112C > T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone 40:1655–1661
Baxter P (2003) Pyridoxine-dependent seizures: a clinical and biochemical conundrum. Biochim Biophys Acta 1647:36–41
Bossi M, Hoylaerts MF, Millan JL (1993) Modifications in a flexible surface loop modulate the isozyme-specific properties of mammalian alkaline phosphatases. J Biol Chem 268:25409–25416
Brun-Heath I, Ermonval M, Chabrol E, Xiao J, Palkovits M, Lyck R, Miller F, Couraud PO, Mornet E, Fonta C (2011) Differential expression of the bone and the liver tissue non-specific alkaline phosphatase isoforms in brain tissues. Cell Tissue Res 343:521–536
Brun-Heath I, Lia-Baldini AS, Maillard S, Taillandier A, Utsch B, Nunes ME, Serre JL, Mornet E (2007) Delayed transport of tissue-nonspecific alkaline phosphatase with missense mutations causing hypophosphatasia. Eur J Med Genet 50:367–378
Brun-Heath I, Taillandier A, Serre JL, Mornet E (2005) Characterization of 11 novel mutations in the tissue non-specific alkaline phosphatase gene responsible for hypophosphatasia and genotype-phenotype correlations. Mol Genet Metab 84:273–277
Cai G, Michigami T, Yamamoto T, Yasui N, Satomura K, Yamagata M, Shima M, Nakajima S, Mushiake S, Okada S, Ozono K (1998) Analysis of localization of mutated tissue-nonspecific alkaline phosphatase proteins associated with neonatal hypophosphatasia using green fluorescent protein chimeras. J Clin Endocrinol Metab 83:3936–3942
Di Mauro S, Manes T, Hessle L, Kozlenkov A, Pizauro JM, Hoylaerts MF, Millan JL (2002) Kinetic characterization of hypophosphatasia mutations with physiological substrates. J Bone Miner Res 17:1383–1391
Eastman JR, Bixler D (1983) Clinical, laboratory, and genetic investigations of hypophosphatasia: support for autosomal dominant inheritance with homozygous lethality. J Craniofac Genet Dev Biol 3:213–234
Eberic FHS, Pralle H, Kabish A (1984) Adult hypophosphatasia without apparent skeletal disease: “ondotohypophosphatasia” in four heterozygote members of a family. Klin Wochenschr 62:371
Fallon MD, Whyte MP, Teitelbaum SL (1980) Stereospecific inhibition of alkaline phosphatase by L-tetramisole prevents in vitro cartilage calcification. Lab Invest 43:489–494
Fauvert D, Brun-Heath I, Lia-Baldini AS, Bellazi L, Taillandier A, Serre JL, de Mazancourt P, Mornet E (2009) Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet 10:51
Fonta C, Negyessy L, Renaud L, Barone P (2004) Areal and subcellular localization of the ubiquitous alkaline phosphatase in the primate cerebral cortex: evidence for a role in neurotransmission. Cereb Cortex 14:595–609
Fonta C, Negyessy L, Renaud L, Barone P (2005) Postnatal development of alkaline phosphatase activity correlates with the maturation of neurotransmission in the cerebral cortex. J Comp Neurol 486:179–196
Fraser D (1957) Hypophosphatasia. Am J Med 22:730–746
Fukushi-Irie M, Ito M, Amaya Y, Amizuka N, Ozawa H, Omura S, Ikehara Y, Oda K (2000) Possible interference between tissue-non-specific alkaline phosphatase with an Arg 54– > Cys substitution and a counter part with an Asp 277– > Ala substitution found in a compound heterozygote associated with severe hypophosphatasia. Biochem J 348(Pt 3):633–642
Fukushi M, Amizuka N, Hoshi K, Ozawa H, Kumagai H, Omura S, Misumi Y, Ikehara Y, Oda K (1998) Intracellular retention and degradation of tissue-nonspecific alkaline phosphatase with a Gly 317– > Asp substitution associated with lethal hypophosphatasia. Biochem Biophys Res Commun 246:613–618
Greenberg CR, Evans JA, McKendry-Smith S, Redekopp S, Haworth JC, Mulivor R, Chodirker BN (1990) Infantile hypophosphatasia: localization within chromosome region 1 p 36.1–34 and prenatal diagnosis using linked DNA markers. Am J Hum Genet 46:286–292
Greenberg CR, Taylor CL, Haworth JC, Seargeant LE, Philipps S, Triggs-Raine B, Chodirker BN (1993) A homoallelic Gly317– > Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites. Genomics 17:215–217
Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millan JL (2004) Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164:1199–1209
Hawrylak K, Stinson RA (1987) Tetrameric alkaline phosphatase from human liver is converted to dimers by phosphatidylinositol phospholipase C. FEBS Lett 212:289–291
Henthorn PS, Raducha M, Fedde KN, Lafferty MA, Whyte MP (1992) Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proc Natl Acad Sci U S A 89:9924–9928
Henthorn PS, Whyte MP (1995) Infantile hypophosphatasia: successful prenatal assessment by testing for tissue-non-specific alkaline phosphatase isoenzyme gene mutations. Prenat Diagn 15:1001–1006
Herasse M, Spentchian M, Taillandier A, Keppler-Noreuil K, Fliorito AN, Bergoffen J, Wallerstein R, Muti C, Simon-Bouy B, Mornet E (2003) Molecular study of three cases of odontohypophosphatasia resulting from heterozygosity for mutations in the tissue non-specific alkaline phosphatase gene. J Med Genet 40:605–609
Herasse M, Spentchian M, Taillandier A, Mornet E (2002) Evidence of a founder effect for the tissue-nonspecific alkaline phosphatase (TNSALP) gene E174 K mutation in hypophosphatasia patients. Eur J Hum Genet 10:666–668
Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL (2002) Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A 99:9445–9449
Ho AM, Johnson MD, Kingsley DM (2000) Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289:265–270
Horn D, Krawitz P, Mannhardt A, Korenke GC, Meinecke P (2011) Hyperphosphatasia-mental retardation syndrome due to PIGV mutations: expanded clinical spectrum. Am J Med Genet A 155A:1917–1922
Hoylaerts MF, Ding L, Narisawa S, Van Kerckhoven S, Millan JL (2006) Mammalian alkaline phosphatase catalysis requires active site structure stabilization via the N-terminal amino acid microenvironment. Biochemistry 45:9756–9766
Hoylaerts MF, Manes T, Millan JL (1997) Mammalian alkaline phosphatases are allosteric enzymes. J Biol Chem 272:22781–22787
Hoylaerts MF, Millan JL (1991) Site-directed mutagenesis and epitope-mapped monoclonal antibodies define a catalytically important conformational difference between human placental and germ cell alkaline phosphatase. Eur J Biochem 202:605–616
Hu JC, Plaetke R, Mornet E, Zhang C, Sun X, Thomas HF, Simmer JP (2000) Characterization of a family with dominant hypophosphatasia. Eur J Oral Sci 108:189–194
Ishida Y, Komaru K, Ito M, Amaya Y, Kohno S, Oda K (2003) Tissue-nonspecific alkaline phosphatase with an Asp (289)– > Val mutation fails to reach the cell surface and undergoes proteasome-mediated degradation. J Biochem (Tokyo) 134:63–70
Ishida Y, Komaru K, Oda K (2011) Molecular characterization of tissue-nonspecific alkaline phosphatase with an Ala to Thr substitution at position 116 associated with dominantly inherited hypophosphatasia. Biochim Biophys Acta 1812:326–332
Ito M, Amizuka N, Ozawa H, Oda K (2002) Retention at the cis-Golgi and delayed degradation of tissue-non-specific alkaline phosphatase with an Asn 153– > Asp substitution, a cause of perinatal hypophosphatasia. Biochem J 361:473–480
Kim EE, Wyckoff HW (1991) Reaction mechanism of alkaline phosphatase based on crystal structures two-metal ion catalysis. J Mol Biol 218:449–464
Komaru K, Ishida Y, Amaya Y, Goseki-Sone M, Orimo H, Oda K (2005) Novel aggregate formation of a frame-shift mutant protein of tissue-nonspecific alkaline phosphatase is ascribed to three cysteine residues in the C-terminal extension. Retarded secretion and proteasomal degradation. FEBS J 272:1704–1717
Kozlenkov A, Le Du MH, Cuniasse P, Ny T, Hoylaerts MF, Millan JL (2004) Residues determining the binding specificity of uncompetitive inhibitors to tissue-nonspecific alkaline phosphatase. J Bone Miner Res 19:1862–1872
Krawitz PM, Murakami Y, Hecht J, Kruger U, Holder SE, Mortier GR, Delle Chiaie B, De Baere E, Thompson MD, Roscioli T, Kielbasa S, Kinoshita T, Mundlos S, Robinson PN, Horn D (2012) Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation. Am J Hum Genet 91:146–151
Krawitz PM, Murakami Y, Riess A, Hietala M, Kruger U, Zhu N, Kinoshita T, Mundlos S, Hecht J, Robinson PN, Horn D (2013) PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome. Am J Hum Genet 92:584–589
Krawitz PM, Schweiger MR, Rodelsperger C, Marcelis C, Kolsch U, Meisel C, Stephani F et al (2010) Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet 42:827–829
Le Du MH, Millan JL (2002) Structural evidence of functional divergence in human alkaline phosphatases. J Biol Chem 277:49808–49814
Le Du MH, Stigbrand T, Taussig MJ, Menez A, Stura EA (2001) Crystal structure of alkaline phosphatase from human placenta at 1.8 A resolution. Implication for a substrate specificity. J Biol Chem 276:9158–9165
Lia-Baldini AS, Brun-Heath I, Carrion C, Simon-Bouy B, Serre JL, Nunes ME, Mornet E (2008) A new mechanism of dominance in hypophosphatasia: the mutated protein can disturb the cell localization of the wild-type protein. Hum Genet 123:429–432
Lia-Baldini AS, Muller F, Taillandier A, Gibrat JF, Mouchard M, Robin B, Simon-Bouy B, Serre JL, Aylsworth AS, Bieth E, Delanote S, Freisinger P, Hu JC, Krohn HP, Nunes ME, Mornet E (2001) A molecular approach to dominance in hypophosphatasia. Hum Genet 109:99–108
Litmanovitz Reish O, Dolfin T, Arnon S, Regev R, Grinshpan G, Yamazaki M, Ozono K (2002) Glu274Lys/Gly309Arg mutation of the tissue-nonspecific alkaline phosphatase gene in neonatal hypophosphatasia associated with convulsions. J Inherit Metab Dis 25:35–40
Matsuura S, Kishi F, Kajii T (1990) Characterization of a 5’-flanking region of the human liver/bone/kidney alkaline phosphatase gene: two kinds of mRNA from a single gene. Biochem Biophys Res Commun 168:993–1000
Mentrup B, Marschall C, Barvencik F, Amling M, Plendl H, Jakob F, Beck C (2011) Functional characterization of a novel mutation localized in the start codon of the tissue-nonspecific alkaline phosphatase gene. Bone 48:1401–1408
Meyer JL (1984) Can biological calcification occur in the presence of pyrophosphate? Arch Biochem Biophys 231:1–8
Michigami T, Uchihashi T, Suzuki A, Tachikawa K, Nakajima S, Ozono K (2005) Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia. Eur J Pediatr 164:277–282
Millan J (2006) Mammalian alkaline phosphatases: from biology to applications in medicine and biotechnology. Wiley-VCH Verlag GmbH, Weinheim
Millan JL (1992) Alkaline phosphatase as a reporter of cancerous transformation. Clin Chim Acta 209:123–129
Moore CA, Curry CJ, Henthorn PS, Smith JA, Smith JC, O’Lague P, Coburn SP, Weaver DD, Whyte MP (1999) Mild autosomal dominant hypophosphatasia: in utero presentation in two families. Am J Med Genet 86:410–415
Mornet E (2008) Hypophosphatasia. Best Pract Res Clin Rheumatol 22:113–127
Mornet E, Muller F, Ngo S, Taillandier A, Simon-Bouy B, Maire I, Oury JF (1999) Correlation of alkaline phosphatase (ALP) determination and analysis of the tissue non-specific ALP gene in prenatal diagnosis of severe hypophosphatasia. Prenat Diagn 19:755–757
Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Menez A, Le Du MH (2001) Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization. J Biol Chem 276:31171–31178
Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B (2011) A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet 75:439–445
Muller HL, Yamazaki M, Michigami T, Kageyama T, Schonau E, Schneider P, Ozono K (2000) Asp361Val Mutant of alkaline phosphatase found in patients with dominantly inherited hypophosphatasia inhibits the activity of the wild-type enzyme. J Clin Endocrinol Metab 85:743–747
Mumm S, Wenkert D, Zhang X, Geimer M, Zerega J, MPW (2007) Hypophosphatasia: the c.1133A > T, D378 V transversion is the most common American TNSALP mutation. In: Paper presented at Fifth International Alkaline Phosphatase Symposium: Understanding alkaline phosphatase function—Pathophysiology and treatment of Hypophosphatasia and other AP-related diseases. Huningue, France
Murakami Y, Kanzawa N, Saito K, Krawitz PM, Mundlos S, Robinson PN, Karadimitris A, Maeda Y, Kinoshita T (2012) Mechanism for release of alkaline phosphatase caused by glycosylphosphatidylinositol deficiency in patients with hyperphosphatasia mental retardation syndrome. J Biol Chem 287:6318–6325
Narisawa S, Hasegawa H, Watanabe K, Millan JL (1994) Stage-specific expression of alkaline phosphatase during neural development in the mouse. Dev Dyn 201:227–235
Nasu M, Ito M, Ishida Y, Numa N, Komaru K, Nomura S, Oda K (2006) Aberrant interchain disulfide bridge of tissue-nonspecific alkaline phosphatase with an Arg 433– > Cys substitution associated with severe hypophosphatasia. FEBS J 273:5612–5624
Numa N, Ishida Y, Nasu M, Sohda M, Misumi Y, Noda T, Oda K (2008) Molecular basis of perinatal hypophosphatasia with tissue-nonspecific alkaline phosphatase bearing a conservative replacement of valine by alanine at position 406. Structural importance of the crown domain. FEBS J 275:2727–2737
Nunes ML, Mugnol F, Bica I, Fiori RM (2002) Pyridoxine-dependent seizures associated with hypophosphatasia in a newborn. J Child Neurol 17:222–224
Orimo H (2010) The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nihon Med Sch 77:4–12
Orimo H, Nakajima E, Hayashi Z, Kijima K, Watanabe A, Tenjin H, Araki T, Shimada T (1996) First-trimester prenatal molecular diagnosis of infantile hypophosphatasia in a Japanese family. Prenat Diagn 16:559–563
Pauli RM, Modaff P, Sipes SL, Whyte MP (1999) Mild hypophosphatasia mimicking severe osteogenesis imperfecta in utero: bent but not broken. Am J Med Genet 86:434–438
Petkovic Ramadza D, Stipoljev F, Sarnavka V, Begovic D, Potocki K, Fumic K, Mornet E, Baric I (2009) Hypophosphatasia: phenotypic variability and possible Croatian origin of the c.1402 g > A mutation of TNSALP gene. Coll Antropol 33:1255–1258
Rasmussen K (1968) Phosphorylethanolamine and hypophosphatasia. Dan Med Bull 15(Suppl 2):1–112
Rezende AA, Pizauro JM, Ciancaglini P, Leone FA (1994) Phosphodiesterase activity is a novel property of alkaline phosphatase from osseous plate. Biochem J 301(Pt 2):517–522
Rodrigues TL, Foster BL, Silverio KG, Martins L, Casati MZ, Sallum EA, Somerman MJ, Nociti FH (2011) Correction of Hypophosphatasia (Hpp) Associated Mineralization Deficiencies In vitro by Phosphate/Pyrophosphate Modulation in Periodontal Ligament Cells. J Periodontol
Satou Y, Al-Shawafi HA, Sultana S, Makita S, Sohda M, Oda K (2012) Disulfide bonds are critical for tissue-nonspecific alkaline phosphatase function revealed by analysis of mutant proteins bearing a C(201)-Y or C(489)-S substitution associated with severe hypophosphatasia. Biochim Biophys Acta 1822:581–588
Say JC, Ciuffi K, Furriel RP, Ciancaglini P, Leone FA (1991) Alkaline phosphatase from rat osseous plates: purification and biochemical characterization of a soluble form. Biochim Biophys Acta 1074:256–262
Schwartz JH, Lipmann F (1961) Phosphate incorporation into alkaline phosphatase of E. coli. Proc Natl Acad Sci U S A 47:1996–2005
Shibata H, Fukushi M, Igarashi A, Misumi Y, Ikehara Y, Ohashi Y, Oda K (1998) Defective intracellular transport of tissue-nonspecific alkaline phosphatase with an Ala 162– > Thr mutation associated with lethal hypophosphatasia. J Biochem (Tokyo) 123:968–977
Spentchian M, Brun-Heath I, Taillandier A, Fauvert D, Serre JL, Simon-Bouy B, Carvalho F, Grochova I, Mehta SG, Muller G, Oberstein SL, Ogur G, Sharif S, Mornet E (2006) Characterization of Missense Mutations and Large Deletions in the ALPL Gene by Sequencing and Quantitative Multiplex PCR of Short Fragments. Genet Test 10:252–257
Stigbrand T (1984) Present status and future trends of human alkaline phosphatases. Prog Clin Biol Res 166:3–14
Street SE, Kramer NJ, Walsh PL, Taylor-Blake B, Yadav MC, King IF, Vihko P, Wightman RM, Millan JL, Zylka MJ (2013) Tissue-Nonspecific Alkaline Phosphatase Acts Redundantly with PAP and NT5E to Generate Adenosine in the Dorsal Spinal Cord. J Neurosci 33:11314–11322
Studer M, Terao M, Gianni M, Garattini E (1991) Characterization of a second promoter for the mouse liver/bone/kidney-type alkaline phosphatase gene: cell and tissue specific expression. Biochem Biophys Res Commun 179:1352–1360
Sultana S, Al-Shawafi HA, Makita S, Sohda M, Amizuka N, Takagi R, Oda K (2013) An asparagine at position 417 of tissue-nonspecific alkaline phosphatase is essential for its structure and function as revealed by analysis of the N417S mutation associated with severe hypophosphatasia. Mol Genet Metab 109:282–288
Taillandier A, Sallinen SL, Brun-Heath I, De Mazancourt P, Serre JL, Mornet E (2005) Childhood hypophosphatasia due to a de novo missense mutation in the tissue-nonspecific alkaline phosphatase gene. J Clin Endocrinol Metab 90:2436–2439
Takinami H, Goseki-Sone M, Watanabe H, Orimo H, Hamatani R, Fukushi-Irie M, Ishikawa I (2004) The mutant (F310L and V365I) tissue-nonspecific alkaline phosphatase gene from hypophosphatasia. J Med Dent Sci 51:67–74
Terao M, Studer M, Gianni M, Garattini E (1990) Isolation and characterization of the mouse liver/bone/kidney-type alkaline phosphatase gene. Biochem J 268:641–648
Thompson MD, Killoran A, Percy ME, Nezarati M, Cole DE, Hwang PA (2006) Hyperphosphatasia with neurologic deficit: a pyridoxine-responsive seizure disorder? Pediatr Neurol 34:303–307
Thompson MD, Roscioli T, Marcelis C, Nezarati MM, Stolte-Dijkstra I, Sharom FJ, Lu P, Phillips JA, Sweeney E, Robinson PN, Krawitz P, Yntema HG, Andrade DM, Brunner HG, Cole DE (2012) Phenotypic variability in hyperphosphatasia with seizures and neurologic deficit (Mabry syndrome). Am J Med Genet A 158A:553–558
Toh Y, Yamamoto M, Endo H, Misumi Y, Ikehara Y (1989) Isolation and characterization of a rat liver alkaline phosphatase gene. A single gene with two promoters. Eur J Biochem 182:231–237
Vergnes H, Grozdea J, Denier C, Bourrouillou G, Calvas P, De La Farge F, Valdiguie P, Calot M (2000) Lower alkaline phosphatase activity and occurrence of an abnormal hybrid intestinal/tissue non-specific isoform in Down’s syndrome amniotic fluids. Early Hum Dev 58:17–24
Vittur F, Stagni N, Moro L, de Bernard B (1984) Alkaline phosphatase binds to collagen; a hypothesis on the mechanism of extravesicular mineralization in epiphyseal cartilage. Experientia 40:836–837
Watanabe A, Satoh, S, Fujita, A, Naing, B.T, Orimo, H, Shimada, T (2012) Perinatal (lethal) type of hypophosphatasia resulting from paternal isodisomy of chromosome 1. In: Paper presented at 6th Alkaline Phosphatase and Hypophosphatasia Symposium, May pp 16–19. Huningue, France
Watanabe A, Yamamasu S, Shinagawa T, Suzuki Y, Miyake H, Takeshita T, Orimo H, Shimada T (2007) Prenatal genetic diagnosis of severe perinatal (lethal) hypophosphatasia. J Nippon Med Sch 74:65–69
Watanabe H, Takinami H, Goseki-Sone M, Orimo H, Hamatani R, Ishikawa I (2005) Characterization of the mutant (A115 V) tissue-nonspecific alkaline phosphatase gene from adult-type hypophosphatasia. Biochem Biophys Res Commun 327:124–129
Waymire KG, Mahuren JD, Jaje JM, Guilarte TR, Coburn SP, MacGregor GR (1995) Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet 11:45–51
Weiss MJ, Cole DE, Ray K, Whyte MP, Lafferty MA, Mulivor RA, Harris H (1988a) A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc Natl Acad Sci U S A 85:7666–7669
Weiss MJ, Ray K, Henthorn PS, Lamb B, Kadesch T, Harris H (1988b) Structure of the human liver/bone/kidney alkaline phosphatase gene. J Biol Chem 263:12002–12010
Wende A, Johansson P, Vollrath R, Dyall-Smith M, Oesterhelt D, Grininger M (2010) Structural and biochemical characterization of a halophilic archaeal alkaline phosphatase. J Mol Biol 400:52–62
Wenkert D, McAlister WH, Coburn SP, Zerega JA, Ryan LM, Ericson KL, Hersh JH, Mumm S, Whyte MP (2011) Hypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature review). J Bone Miner Res 26:2389–2398
Whyte M (2001) Hypophosphatasia, vol IV. McGraw-Hill, New-York
Whyte MP (1994) Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15:439–461
Whyte MP, Essmyer K, Geimer M, Mumm S (2006) Homozygosity for TNSALP mutation 1348c > T (Arg433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry. J Pediatr 148:753–758
Whyte MP, Teitelbaum SL, Murphy WA, Bergfeld MA, Avioli LV (1979) Adult hypophosphatasia. Clinical, laboratory, and genetic investigation of a large kindred with review of the literature. Medicine (Baltimore) 58:329–347
Whyte MP, Vrabel LA, Schwartz TD (1982) Adult hypophosphatasia: generalized deficiency of alkaline phosphatase activity demonstrated with cultured skin fibroblasts. Trans Assoc Am Physicians 95:253–263
Wu LN, Genge BR, Lloyd GC, Wuthier RE (1991) Collagen-binding proteins in collagenase-released matrix vesicles from cartilage. Interaction between matrix vesicle proteins and different types of collagen. J Biol Chem 266:1195–1203
Yadav MC, Simao AM, Narisawa S, Huesa C, McKee MD, Farquharson C, Millan JL (2011) Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: a unified model of the mechanisms of initiation of skeletal calcification. J Bone Miner Res 26:286–297
Zhang H, Ke YH, Wang C, Yue H, Hu WW, Gu JM, Zhang ZL (2012) Identification of the mutations in the tissue-nonspecific alkaline phosphatase Gene in two Chinese families with hypophosphatasia. Arch Med Res 43:21–30
Zurutuza L, Muller F, Gibrat JF, Taillandier A, Simon-Bouy B, Serre JL, Mornet E (1999) Correlations of genotype and phenotype in hypophosphatasia. Hum Mol Genet 8:1039–1046
Conflict of Interest
The author states the absence of conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Mornet, E. (2015). Molecular Genetics of Hypophosphatasia and Phenotype-Genotype Correlations. In: Fonta, C., Négyessy, L. (eds) Neuronal Tissue-Nonspecific Alkaline Phosphatase (TNAP). Subcellular Biochemistry, vol 76. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7197-9_2
Download citation
DOI: https://doi.org/10.1007/978-94-017-7197-9_2
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7196-2
Online ISBN: 978-94-017-7197-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)